Board of Directors
John Haurum, MD DPhil
Chairman
Non-executive Director in several European biotech companies: Agomab, CatalYm, Neophore, Storm, Synklino
Jeroen Bakker, PhD
Novo Holdings
Partner at Novo Holdings and part of the Seed Investments team focusing on company creation and early-stage financings
Joël Jean-Mairet, PhD
Ysios Capital
Managing partner and co-founder of Ysios Capital. Co-founded Glycart Biotechnology in 2001
Iyona Rajkomar, MBBS, CFA
Dawn Biopharma
Iyona is Managing Partner at Dawn Biopharma, which is a platform controlled by KKR since May 2023. She was previously at Pontifax. Iyona trained as a physician and is based in London.
Carl Kilander, MD PhD
HealthCap
Partner at HealthCap. Carl co-founded and was CEO of a health-tech start-up exited in 2019. Carl is a Medical Doctor trained at the Karolinska Institute and at Harvard Medical School
Edwin de Graaf, MSc
Gilde Healthcare
Founder and managing partner of Gilde Healthcare, where he is co-responsible for fund management and investment activities of the healthcare venture and growth capital funds
Joel Barrish, PhD
RA Capital
Venture Partner involved in NewCo formation, RA Ventures at RA Capital Management. Formerly Head of Global Discovery Chemistry, Bristol-Myers Squibb, and Co-founder, President and CSO, Jnana Therapeutics.
Ohad Hammer, Msc
Pontifax
Ohad is a Partner at Pontifax, where he is in charge of scouting and project evaluation. He serves as a director in Adcendo, Agomab, Step Pharma and Emergence Therapeutics.